JAMA Internal Medicine 2018;178(11):

Slides:



Advertisements
Similar presentations
 Serum Levels of Phosphorus, Parathyroid Hormone, and Calcium and Risks of Death and Cardiovascular Disease in Individuals With Chronic Kidney Disease:
Advertisements

Is low-dose Aspirin use associated with a reduced risk of colorectal cancer ? a QResearch primary care database analysis Prof Richard Logan, Dr Yana Vinogradova,
Azara Proprietary & Confidential Controlling High Blood Pressure 2014 Measure Changes Improving Patient Outcomes through Data.
6 / 5 / RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 3 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR) ALLHAT.
Clinical Appraisal of an Article on Prognosis The Clinical Question Will the prognosis of patients with gout be affected by the administration allupurinol?
Thomas S. Rector, PhD, Inder S. Anand, MD, David Nelson, PhD, Kristine Ensrud, MD and Ann Bangerter, MS CHF QUERI NETWORK November 8, 2007 VA Medical Center,
Circulating Long-Chain ω-3 Fatty Acids and Incidence of Congestive Heart Failure in Older Adults: The Cardiovascular Health Study Funded by: National Institutes.
2007May221 Journal Club for Analysis of Complex Datasets Frost FJ, Petersen H, Tollestrup K, Skipper B. Influenza and COPD mortality protection as pleiotropic,
Response to Antiretroviral Treatment In an Ethiopian Hospital Samuel Hailemariam, MD, MPH; J Allen McCutchan, MD, MSc Meaza Demissie, MD, PMH, PHD; Alemayehu.
내과 R1 문정락 / prof. 정경환 N Engl J Med 369;10 nejm.org 932 september 5, 2013.
Methods and Statistical analysis. A brief presentation. Markos Kashiouris, M.D.
SURVIVAL IN ADULTS UNDERGOING KIDNEY TRANSPLANT FROM CADAVERIC DONORS COMPARED WITH PATIENTS ON WAITING LIST IN ARGENTINA Bisigniano, Liliana.
Section 1: CKD Epidemiology
Obesity in the end stage kidney disease population
Associate Professor, Honorary Consultant Cardiologist
- Higher SBP visit-to-visit variability (SBV) has been associated
Case 66 year old male with PMH of HTN, DM, ESRD on renal replacement TIW, stroke in 2011 with right side residual weakness, atrial fibrillation, currently.
From: Benefits and Harms of Statin Therapy for Persons With Chronic Kidney DiseaseA Systematic Review and Meta-analysis Ann Intern Med. 2012;157(4):
The SPRINT Research Group
Wei Wang, Long Jiang Zhang*, Guang Ming Lu*
Golden Rules to Keep Kidneys Healthy
UK Renal Registry 10th Annual Report 2007
Assessment of Achieved Clinic and Ambulatory Blood Pressure Recordings and Outcomes During Treatment in Hypertensive Patients With CKD: A Multicenter.
Date:2017/10/03 Presenter: Wen-Ching Lan
Vietnam Authority of HIV/AIDS Control
Clinical Appraisal of an Article on Prognosis
Clinical outcome after SVR: Veterans Affairs
Assessment of Achieved Clinic and Ambulatory Blood Pressure Recordings and Outcomes During Treatment in Hypertensive Patients With CKD: A Multicenter.
Introduction: Alarming Statistics Causes of Death in Prevalent Dialysis Patients,
Presenter: Wen-Ching Lan Date: 2018/08/01
Gout Management.
Systolic Blood Pressure Intervention Trial (SPRINT)
Figure 6 Approach to drug management in patients with acute kidney disease (AKD) Figure 6 | Approach to drug management in patients with acute kidney disease.
Bhandari et al. Am J Nephrol 2017;45: (DOI: / )
Treat to Target in Gout.
The effect of acute kidney injury after revascularization on the development of chronic kidney disease and mortality in patients with chronic limb ischemia 
Renal function and outcome after heart transplantation
Mitchell H. Rosner, W. Kline Bolton  Kidney International 
Volume 83, Issue 3, Pages (March 2013)
2018 Annual Data Report Volume 1: Chronic Kidney Disease
These slides highlight an educational report from a late-breaking clinical trials presentation at the 58th Annual Scientific Session of the American College.
Alcohol Quantity and Type on Risk of Recurrent Gout Attacks: An Internet-based Case- crossover Study  Tuhina Neogi, MD, PhD, Clara Chen, MHS, Jingbo Niu,
Outcomes of cardiac surgery in chronic kidney disease
Jessica W. Weiss, MD, Eric S. Johnson, PhD, Amanda Petrik, MS, David H
Effects of a Nationwide Predialysis Educational Program on Modality Choice, Vascular Access, and Patient Outcomes  Eduardo Lacson, MD, MPH, Weiling Wang,
The association of chronic kidney disease and dialysis treatment with foot ulceration and major amputation  Jeroen Otte, MD, MSc, Jaap J. van Netten,
Medical Nutrition Therapy for Chronic Kidney Disease Improves Biomarkers and Slows Time to Dialysis  Desirée de Waal, MS, RD, CD, FAND, Emily Heaslip,
Jeffrey E. Korte, PhD BMTRY 747: Foundations of Epidemiology II
Patient and Graft Survival Following Kidney Transplantation in Recipients With Cystinosis: A Cohort Study  Rebecca A. Spicer, MBChB, Philip A. Clayton,
UK Renal Registry 13th Annual Report
The association of chronic kidney disease and dialysis treatment with foot ulceration and major amputation  Jeroen Otte, MD, MSc, Jaap J. van Netten,
Chronic Kidney Disease, Basal Insulin Glargine, and Health Outcomes in People with Dysglycemia: The ORIGIN Study  Vasilios Papademetriou, MD, DSc, Eric.
I. Introduction American Journal of Kidney Diseases
The effect of acute kidney injury after revascularization on the development of chronic kidney disease and mortality in patients with chronic limb ischemia 
GFR Decline as an End Point for Clinical Trials in CKD: A Scientific Workshop Sponsored by the National Kidney Foundation and the US Food and Drug Administration 
Comprehensive Public Health Strategies for Preventing the Development, Progression, and Complications of CKD: Report of an Expert Panel Convened by the.
Prediction of ESRD and Death Among People With CKD: The Chronic Renal Impairment in Birmingham (CRIB) Prospective Cohort Study  Martin J. Landray, PhD,
Impact of Educational Attainment on Health Outcomes in Moderate to Severe CKD  Rachael L. Morton, PhD, Iryna Schlackow, DPhil, Natalie Staplin, PhD, Alastair.
Q.A. Truong et al. Circ Cardiovasc Qual Outcomes 2011;4:
Critical Appraisal วิจารณญาณ
American Journal of Kidney Diseases
Volume 86, Issue 1, Pages (July 2014)
Survival by time of day of hemodialysis: analysis of United States renal data system dialysis morbidity and mortality waves III/IV  Kevin C Abbott, MD,
Volume 76, Issue 8, Pages (October 2009)
Michael J. Germain, MD, Sara N. Davison, MD, Alvin H. Moss, MD 
Unraveling the racial disparities associated with kidney disease1
Collecting and using patient and treatment center data to improve care: Adequacy of hemodialysis and end-stage renal disease surveillance1  William M.
The Impact of Acute Renal Failure on Early and Late Outcomes After Thoracic Aortic Endovascular Repair  Joseph D. Drews, BS, Himanshu J. Patel, MD, David.
Risk for chronic kidney disease (CKD) among Olmsted County, MN, stone formers and control subjects. Risk for chronic kidney disease (CKD) among Olmsted.
Dialysis outcomes in Australia & New Zealand
Presentation transcript:

JAMA Internal Medicine 2018;178(11):1526-1533. Association of Chronic Kidney Disease with Allopurinol Use in Gout Treatment Ana Beatriz Vargas-Santos, MD; Christine E. Peloquin, MPH; Yuqing Zhang, DSc; Tuhina Neogi, MD, PhD JAMA Internal Medicine 2018;178(11):1526-1533.

Research Question What is the association of allopurinol use in patients with gout with the risk of developing chronic kidney disease stage 3 or higher?

痛風的成因 尿酸過高 尿酸生成過多 尿酸排除速率過慢 尿酸代謝 異常 尿酸結晶,沉積關節腔 關節炎

Importance Clinicians are often cautious about use of allopurinol in patients with gout when renal function declines there is no evidence that allopurinol is nephrotoxic

Objective   To assess the association of allopurinol use in gout with the risk of developing chronic kidney disease stage 3 or higher.

Study Design time-stratified PSM cohort study data sources: UK GPs (The Health Improvement Network)

Study Design Included Excluded 18-89 years, new dx. gout 2000/1/1−2014/12/31 @ last 1 year Excluded prior CKD stage 3↑ (& ESRD) prior urate-lowering therapy prior other conditions due to time-stratified PSM cohort study design

Outcome definition CKD stage 3+ Dialysis Kidney transplant Death

Statistical analysis Cox proportional hazards model Kaplan-Meier curves Sensitivity analysis censoring at exposure status change included all allopurinol initiators (dose <300 mg/d)

Results

Results

Results

Results

Results

Discussion previous studies about allopurinol … gout studies no significant association with renal function but not directly applicable to gout patients gout studies small sample size or not target for gout (hypertensive) same founding with other studies  potential beneficial

Strengths & Limitations large sample new user design potential confounding observational study potential misclassification suboptimal of gout therapy more compliance for allopurinol user possible detection bias

Conclusion Allopurinol was associated with 13% reduction the risk of developing CKD stage 3+

potential indication bias Comments good topic selection well research design potential indication bias U can do it !

Thanks for your attention Any comments?